Kerui Peptide HongKong
Tirzepatide
Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Kerui Peptide HongKong between 20 May 2026 and 5 Aug 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Kerui Peptide HongKong
Tirzepatide
Tested 4 Samples
Last test 5 Aug 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Kerui Peptide HongKong
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
5 Aug 2026
First
20 May 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 5 Aug 2026 | View | 10mg | 10.3mg | +3.0% | 99.90% | June 12, 2026 | Green Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 22 Jul 2026 | View | 10mg | 10.3mg | +3.0% | 99.90% | KERUI/TR10-260606 | White label / Silver crimp / Blue cap | Lab E | Public | |
| 17 Jun 2026 | View | 20mg | 21mg | +5.0% | 99.80% | March 10,2026 | No label / Silver crimp / Black cap | Lab G | Public | |
| 20 May 2026 | View | 60mg | 57.7mg | -3.8% | 99.90% | 2026.04.01 | White Label / Silver Crimp / Orange Cap | Lab E | Public | |